Skip to content

Clinical trials

Observational Breast Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Observational Country / region: Germany Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20034
20051
20061
20071
20081
20092
20103
20115
20124
20134
20144
20152
20164
20176
20181
20197
20208
20214
20227
20236
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51
Recruiting17
Unknown status9
Active, not recruiting5
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital Tuebingen6
AstraZeneca5
Hoffmann-La Roche4
iOMEDICO AG4
Amgen3
Novartis Pharmaceuticals3
Pierre Fabre Pharma GmbH3
Center for Epidemiology and Health Research, Germany2
European Breast Cancer Research Association of Surgical Trialists2
European Organisation for Research and Treatment of Cancer - EORTC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms83
Lung Neoplasms7
Prostatic Neoplasms7
Neoplasms6
Ovarian Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Pancreatic Neoplasms5
Colorectal Neoplasms4
Carcinoma3
Head and Neck Neoplasms3

Trials

Showing 1 to 25 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.